Welcome!

News Feed Item

Diarrhea Global Clinical Trials Review, H1, 2013

NEW YORK, May 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Diarrhea Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0829678/Diarrhea-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Diarrhea Global Clinical Trials Review, H1, 2013

Summary

GlobalData's clinical trial report, "Diarrhea Global Clinical Trials Review, H1, 2013" provides data on the Diarrhea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diarrhea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diarrhea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Diarrhea 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Diarrhea 24
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Diarrhea Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Sanofi 34
Clinical Trial Overview of Sanofi 34
Optimer Pharmaceuticals, Inc. 35
Clinical Trial Overview of Optimer Pharmaceuticals, Inc. 35
Salix Pharmaceuticals, Inc. 36
Clinical Trial Overview of Salix Pharmaceuticals, Inc. 36
Romark Laboratories, L.C. 37
Clinical Trial Overview of Romark Laboratories, L.C. 37
Johnson & Johnson 38
Clinical Trial Overview of Johnson & Johnson 38
Intercell AG 39
Clinical Trial Overview of Intercell AG 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Ipsen S.A. 41
Clinical Trial Overview of Ipsen S.A. 41
Glenmark Pharmaceuticals Ltd. 42
Clinical Trial Overview of Glenmark Pharmaceuticals Ltd. 42
Pfizer Inc. 43
Clinical Trial Overview of Pfizer Inc. 43
Mead Johnson Nutrition Company 44
Clinical Trial Overview of Mead Johnson Nutrition Company 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
AGI Therapeutics plc 46
Clinical Trial Overview of AGI Therapeutics plc 46
NIZO food research BV 47
Clinical Trial Overview of NIZO food research BV 47
Ventria Bioscience 48
Clinical Trial Overview of Ventria Bioscience 48
Bio-K+ International Inc. 49
Clinical Trial Overview of Bio-K+ International Inc. 49
Furiex Pharmaceuticals, Inc. 50
Clinical Trial Overview of Furiex Pharmaceuticals, Inc. 50
Friesland Coberco Dairy Foods Holding N.V. 51
Clinical Trial Overview of Friesland Coberco Dairy Foods Holding N.V. 51
Genzyme Corporation 52
Clinical Trial Overview of Genzyme Corporation 52
Nestle SA 53
Clinical Trial Overview of Nestle SA 53
Clinical Trial Overview of Top Universities / Institutes / Hospitals 54
ICDDR,B 54
Clinical Trial Overview of ICDDR,B 54
U.S. Centers for Disease Control and Prevention 55
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 55
International Vaccine Institute 56
Clinical Trial Overview of International Vaccine Institute 56
The University of Nottingham 57
Clinical Trial Overview of The University of Nottingham 57
The Johns Hopkins Bloomberg School of Public Health 58
Clinical Trial Overview of The Johns Hopkins Bloomberg School of Public Health 58
Aga Khan University 59
Clinical Trial Overview of Aga Khan University 59
Centro Pediatrico Albina de Patino 60
Clinical Trial Overview of Centro Pediatrico Albina de Patino 60
Johns Hopkins University 61
Clinical Trial Overview of Johns Hopkins University 61
University of Virginia 62
Clinical Trial Overview of University of Virginia 62
Mayo Clinic 63
Clinical Trial Overview of Mayo Clinic 63
Christian Medical College 64
Clinical Trial Overview of Christian Medical College 64
University of Pittsburgh 65
Clinical Trial Overview of University of Pittsburgh 65
Seoul National University Hospital 66
Clinical Trial Overview of Seoul National University Hospital 66
London School of Hygiene & Tropical Medicine 67
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 67
Shanghai University of Traditional Chinese Medicine 68
Clinical Trial Overview of Shanghai University of Traditional Chinese Medicine 68
Centre for International Health 69
Clinical Trial Overview of Centre for International Health 69
The University of Texas Health Science Center at Houston 70
Clinical Trial Overview of The University of Texas Health Science Center at Houston 70
John D. Dingell VA Medical Center 71
Clinical Trial Overview of John D. Dingell VA Medical Center 71
Medical University of Warsaw 72
Clinical Trial Overview of Medical University of Warsaw 72
Hadassah Medical Organization 73
Clinical Trial Overview of Hadassah Medical Organization 73
Five Key Clinical Profiles 74
Appendix 123
Abbreviations 123
Definitions 123
Research Methodology 124
Secondary Research 124
About GlobalData 125
Contact Us 125
Disclaimer 125
Source 126

List of Tables

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries, 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries, 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Diarrhea Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Diarrhea Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 34
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Optimer Pharmaceuticals, Inc., 2013* 35
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals, Inc., 2013* 36
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Romark Laboratories, L.C., 2013* 37
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 38
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercell AG, 2013* 39
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 40
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2013* 41
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Glenmark Pharmaceuticals Ltd., 2013* 42
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 43
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mead Johnson Nutrition Company, 2013* 44
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 45
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by AGI Therapeutics plc, 2013* 46
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by NIZO food research BV, 2013* 47
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Ventria Bioscience, 2013* 48
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio-K+ International Inc., 2013* 49
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Furiex Pharmaceuticals, Inc., 2013* 50
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Friesland Coberco Dairy Foods Holding N.V., 2013* 51
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2013* 52
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle SA, 2013* 53
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by ICDDR,B, 2013* 54
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Centers for Disease Control and Prevention, 2013* 55
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by International Vaccine Institute, 2013* 56
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Nottingham, 2013* 57
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins Bloomberg School of Public Health, 2013* 58
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2013* 59
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro Pediatrico Albina de Patino, 2013* 60
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 61
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2013* 62
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 63
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Christian Medical College, 2013* 64
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 65
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 66
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2013* 67
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai University of Traditional Chinese Medicine, 2013* 68
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre for International Health, 2013* 69
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2013* 70
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by John D. Dingell VA Medical Center, 2013* 71
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Warsaw, 2013* 72
Diarrhea Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 73

List of Figures

Diarrhea Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Diarrhea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Diarrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Diarrhea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Diarrhea Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Diarrhea Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Diarrhea Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Diarrhea Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Diarrhea Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Diarrhea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Diarrhea Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Diarrhea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Diarrhea Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Diarrhea Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Diarrhea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Diarrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 28
Diarrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Diarrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Diarrhea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 33
GlobalData Methodology 124

To order this report:
Drug_Discovery_and_Development Industry:
Diarrhea Global Clinical Trials Review, H1, 2013

__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will d...
While DevOps most critically and famously fosters collaboration, communication, and integration through cultural change, culture is more of an output than an input. In order to actively drive cultural evolution, organizations must make substantial organizational and process changes, and adopt new technologies, to encourage a DevOps culture. Moderated by Andi Mann, panelists discussed how to balance these three pillars of DevOps, where to focus attention (and resources), where organizations might...
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
When building large, cloud-based applications that operate at a high scale, it's important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. "Fly two mistakes high" is an old adage in the radio control airplane hobby. It means, fly high enough so that if you make a mistake, you can continue flying with room to still make mistakes. In his session at 18th Cloud Expo, Le...
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by ...
As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more than 24 years of IT Operations experience with a focus on highly-scalable architectures.
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
CI/CD is conceptually straightforward, yet often technically intricate to implement since it requires time and opportunities to develop intimate understanding on not only DevOps processes and operations, but likely product integrations with multiple platforms. This session intends to bridge the gap by offering an intense learning experience while witnessing the processes and operations to build from zero to a simple, yet functional CI/CD pipeline integrated with Jenkins, Github, Docker and Azure...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Dhiraj Sehgal works in Delphix's product and solution organization. His focus has been DevOps, DataOps, private cloud and datacenters customers, technologies and products. He has wealth of experience in cloud focused and virtualized technologies ranging from compute, networking to storage. He has spoken at Cloud Expo for last 3 years now in New York and Santa Clara.
Enterprises are striving to become digital businesses for differentiated innovation and customer-centricity. Traditionally, they focused on digitizing processes and paper workflow. To be a disruptor and compete against new players, they need to gain insight into business data and innovate at scale. Cloud and cognitive technologies can help them leverage hidden data in SAP/ERP systems to fuel their businesses to accelerate digital transformation success.
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.